A Study on Vattathiruppi Nei for the Treatment of Erumal in Children.

Preclinical and Clinical Evaluation of the Effect On Oral Administration of VATTATHIRUPPI NEI for the treatment of ERUMAL (BRONCHITIS) in Children. - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062700

Enrollment

Registered

2024-02-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

Intervention1: VATTATHIRUPPI NEI(Internal Administration): Should be administrated orally twice a day before food.Dosage(according to the age of the patients)5 to 15Ml.Duration-14 days. Intervention2:

Eligibility

Inclusion criteria

Inclusion criteria: Upper and lower respiratory tract infection Rhinitis Nasobronchial allergy Breathing difficulty Dry cough or cough with phlegm Sore throat

Exclusion criteria

Exclusion criteria: Children below 3 years High grade fever Severe asthma Whooping cough Pneumonia Tuberculosis Empyema Paroxysmal noctural dyspnea

Design outcomes

Primary

Measure	Time frame
This Study will help to understand the effects of VATTATHIRUPPI NEI for the treatment of ERUMAL (BRONCHITIS) in Children.Timepoint: 2 years	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr J Sriram MD S

Government Siddha Medical College, Palayamkottai, Tirunelveli.

sriramsiddha@gmail.com9486811230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026